Literature DB >> 2553997

Morphology of mineral deposits on encrusted urinary catheters investigated by scanning electron microscopy.

A J Cox1, D W Hukins.   

Abstract

Struvite and hydroxyapatite were precipitated from artificial urine onto the surfaces of catheter materials by the controlled addition of urease. They were precipitated both together and separately (by omitting components of the artificial urine), and with and without the inclusion of albumin (which was intended to mimic the proteinaceous debris found in infected urine). Precipitates were identified by X-ray powder diffraction and the artificially encrusted surfaces examined by scanning electron microscopy. In the presence of protein, hydroxyapatite was precipitated as a poorly crystalline form which aggregated to form a crust. Struvite crystals could be easily identified under the scanning electron microscope by their relatively large size and characteristic appearance. Fifteen encrusted catheters from patients were also examined by scanning electron microscopy, and a further six using X-ray microanalysis. Their appearance was very similar to that of the materials encrusted in vitro. Encrustation involves the formation of hydroxyapatite and the growth of struvite crystals, intimately associated with bacteria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553997     DOI: 10.1016/s0022-5347(17)39095-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

1.  Factors affecting crystal precipitation from urine in individuals with long-term urinary catheters colonized with urease-positive bacterial species.

Authors:  Sunil Mathur; Marc T E Suller; David J Stickler; Roger C L Feneley
Journal:  Urol Res       Date:  2006-02-02

2.  A study of the structure of the crystalline bacterial biofilms that can encrust and block silver Foley catheters.

Authors:  Sheridan D Morgan; Deborah Rigby; David J Stickler
Journal:  Urol Res       Date:  2009-02-03

3.  Studies on the formation of crystalline bacterial biofilms on urethral catheters.

Authors:  D Stickler; N Morris; M C Moreno; N Sabbuba
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

4.  Infection of catheterised patients: bacterial colonisation of encrusted Foley catheters shown by scanning electron microscopy.

Authors:  A J Cox; D W Hukins; T M Sutton
Journal:  Urol Res       Date:  1989

5.  Effect of phytate on crystallization on ureteral stents and bacterial attachment: an in vitro study.

Authors:  Paula Calvó; Margalida Mateu-Borras; Antonia Costa-Bauza; Sebastián Albertí; Fèlix Grases
Journal:  Urolithiasis       Date:  2022-09-05       Impact factor: 2.861

6.  Proteus mirabilis biofilms and the encrustation of urethral catheters.

Authors:  D Stickler; L Ganderton; J King; J Nettleton; C Winters
Journal:  Urol Res       Date:  1993

7.  In Situ Biomineralization and Particle Deposition Distinctively Mediate Biofilm Susceptibility to Chlorine.

Authors:  Xiaobao Li; David L Chopp; William A Russin; Paul T Brannon; Matthew R Parsek; Aaron I Packman
Journal:  Appl Environ Microbiol       Date:  2016-05-02       Impact factor: 4.792

8.  Elucidating the genetic basis of crystalline biofilm formation in Proteus mirabilis.

Authors:  N Holling; D Lednor; S Tsang; A Bissell; L Campbell; J Nzakizwanayo; C Dedi; J A Hawthorne; G Hanlon; L A Ogilvie; J P Salvage; B A Patel; L M Barnes; B V Jones
Journal:  Infect Immun       Date:  2014-01-27       Impact factor: 3.441

9.  Ultrastructure of Proteus mirabilis swarmer cell rafts and role of swarming in catheter-associated urinary tract infection.

Authors:  Brian V Jones; Robert Young; Eshwar Mahenthiralingam; David J Stickler
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

10.  Soft robotic concepts in catheter design: an on-demand fouling-release urinary catheter.

Authors:  Vrad Levering; Qiming Wang; Phanindhar Shivapooja; Xuanhe Zhao; Gabriel P López
Journal:  Adv Healthc Mater       Date:  2014-03-25       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.